A Multicenter Phase II Clinical Trial of Neoadjuvant Trabectedin (Yondelis) in Patients With Localized Myxoid / Round Cell Liposarcoma.
Phase of Trial: Phase II
Latest Information Update: 20 Jun 2014
At a glance
- Drugs Trabectedin (Primary)
- Indications Liposarcoma
- Focus Pharmacogenomic; Therapeutic Use
- Sponsors Janssen Research & Development
- 02 Jun 2012 Additional locations (Germany) added as reported by European Clinical Trials Database record.
- 24 Mar 2012 This trial has been recruiting in France and completed in Italy.
- 24 Mar 2012 Additional locations (France, Italy) added as reported by European Clinical Trials Database record.